Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Safety and Compliance This product is strictly for laboratory research by qualified professionals
Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes
Phase 2 trials investigated once-weekly subcutaneous doses ranging from 1 mg to 12 mg, administered via a gradual escalation schedule
Download These Required Consent Forms Informed Consent Hormone Optimization Form During your initial visit, you will complete a thorough questionnaire and medical history
At GWCIM, IV therapy is part of your integrative medicine care, and our physicians look at your full health history, your functional medicine labs, and what you actually need before recommending any infusion
